Skip to main content
BB Biotech AG logo

BB Biotech AG — Investor Relations & Filings

Ticker · BION ISIN · CH0027659793 LEI · 391200MBZQNPFHIVKO34 SW Financial and insurance activities
Open in API
Filings indexed 267 across all filing types
Latest filing 2022-04-22 Report Publication Anno…
Country CH Switzerland
Listing SW BION

About BB Biotech AG

https://www.bbbiotech.ch/en/bb-biotech

BB Biotech AG is an investment company specializing in the fast-growing biotechnology market. With over 30 years of experience, it is one of the world's largest investors in this sector. The company's investment strategy focuses on a portfolio of publicly listed companies that are developing and commercializing novel drugs. These target companies are selected for their potential to create significant value for the healthcare system by addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
BB Biotech AG publishes its interim report
Report Publication Announcement Classification · 100% confidence The document is a short announcement (approx. 3,000 characters) that informs the public that BB Biotech AG has published its interim report. It provides a link to the actual report rather than containing the full report itself. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA). Q1 2022
2022-04-22 English
Q1 statement / Q1 financial report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report as at 31.03.2022' and contains comprehensive financial data, including consolidated interim financial statements, performance comparisons, and a shareholder letter. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-04-22 English
BB Biotech AG concludes its share buyback program and launches a new buyback program
Transaction in Own Shares Classification · 100% confidence The document is a short news release dated April 12, 2022, announcing that BB Biotech AG has concluded an old share buyback program and immediately launched a new one, authorizing the repurchase of up to 10% of its shares over 36 months. This directly relates to the company's capital structure management and share transactions. The definition for 'Transaction in Own Shares' (POS) covers reports of the company buying back or selling its own shares. Since this is a direct announcement of the initiation and conclusion of share repurchase activities, POS is the most appropriate classification. It is not a comprehensive financial report (10-K, IR) or a general regulatory filing (RNS), but a specific corporate action announcement.
2022-04-12 English
Shareholders at BB Biotech AG's AGM vote in favor of all proposals, approve the dividend of CHF 3.85 per share and elect two new board members
AGM Information Classification · 99% confidence The document explicitly mentions 'Shareholders at BB Biotech AG’s AGM vote in favor of all proposals, approve the dividend of CHF 3.85 per share and elect two new board members'. The key phrase 'AGM' (Annual General Meeting) and the content detailing shareholder votes on proposals, dividend approval, and board elections strongly indicate this is material related to the AGM. Since the document is an announcement summarizing the results of the meeting rather than a presentation (AGM-R) or a proxy statement (DEF 14A/PSI), and it is a formal news release (DGAP-News), the most fitting category is AGM-R, which covers presentations and materials shared during the AGM. Although it contains elements of DVA (voting results) and MANG (board elections), the context is the meeting itself.
2022-03-17 English
BB Biotech AG publishes its 2021 annual report
Report Publication Announcement Classification · 100% confidence The document is explicitly titled "BB Biotech AG publishes its 2021 annual report" and states, "BB Biotech AG published its annual report for fiscal year 2021 today." Although it announces the publication of the annual report, the document is quite substantial (5275 characters) and provides key financial highlights (net loss of CHF 405 mn) and details about the content of the report, including the audited consolidated financial statements and the ESG report. This level of detail suggests it is more than just a brief announcement of availability (RPA). However, the primary function of this specific filing, which is an 'Ad-hoc' announcement via DGAP, is to inform the market that the full Annual Report (10-K equivalent for non-US filers, or the comprehensive annual filing) is now available, often serving as the official release mechanism. Given the context of regulatory filings, when a company announces the publication of its full annual report, it is often classified as a Report Publication Announcement (RPA) if the text itself is the announcement, rather than the full report document. Since the text explicitly states the annual report is published and provides links, it fits the RPA definition best, as it is the announcement *of* the report, not the report itself. If the text were much longer and contained the full audited statements, it would be 10-K. Since it is an announcement of the annual report publication, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule.
2022-02-18 English
BB Biotech AG publishes its 2021 annual report
Report Publication Announcement Classification · 99% confidence The document explicitly states, "BB Biotech AG publishes its 2021 annual report" and references the "Annual report of BB Biotech AG as at December 31, 2021." It mentions containing "audited consolidated financial statements." This strongly indicates the document is related to the Annual Report (10-K). However, the document itself is a news release (indicated by DGAP-News, Media release) announcing the publication of the full report and providing a link to it. According to Rule 2 (The 'MENU VS MEAL' Rule), if the document is an announcement of a report rather than the report itself, it should be classified as a Report Publication Announcement (RPA). The text is short (5134 chars) and serves to inform the market that the Annual Report is now available via a link. Therefore, RPA is the most appropriate classification for this announcement.
2022-02-18 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.